Personalized Medicine
302 articles
Leadership
Board of Directors Scientific Advisory Board Advisory Committee Our Team
A Newly Identified Biomarker Panel Shows Promise in Earlier Pancreatic Cancer Detection
The first pancreatic cancer blood test may soon be a reality, as a biomarker panel from the lab of Dr. Ken Zaret shows promise in early testing.
Aiming to Improve Immunotherapy for Pancreatic Cancer
Dr. Deirdre Cohen discusses clinical trials that aim to improve the effectiveness of immunotherapy for pancreatic cancer.
Two Enzymes May Predict Pancreatic Cancer Severity and Development
Dr. Alexandra Newton and her lab have found that the relationship between two enzymes common to cancer may play a role in pancreatic cancer prognosis.
ASCO Annual Conference: Highlights in Pancreatic Cancer Research
Dr. Allyson Ocean reviews some of the latest pancreatic cancer research results, including new treatments for some patients.
Machine-Learning Assay May Improve Pancreatic Cyst Management
Dr. Anne Marie Lennon explains CompCyst, the artificial intelligence-based assay that can determine the best treatment for pancreatic cysts.
Study Shows Fungi Boost Pancreatic Cancer Development and Growth
Drs. George Miller and Berk Aykut are leading research into the role of fungi in the growth and development of pancreatic cancer.
The Future of Pancreatic Cancer Treatment
Dr. Anil Rustgi discusses the latest developments in pancreatic cancer treatment and the direction of current research in early detection.
Studying a New Approach for the Liquid Biopsy
Drs. Allyson Ocean and Ying-Hsiu Su lead a liquid biopsy pilot study looking for KRAS proteins in urine, to detect pancreatic cancer.